BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

BMT News

March 17, 2017
Market watch: Upcoming market catalysts in Q2 2017

December 29, 2016
Market watch: Upcoming market catalysts in Q1 2017

September 29, 2016
Market watch: Upcoming market catalysts in Q4 2016

July 20, 2016
MarketWatch: These drugs could cut American health costs by $250 billion (if only we could take them)

June 10, 2016
Market watch: Upcoming market catalysts in Q3 2016

May 25, 2016
BIO Releases Largest Ever Study on Clinical Development Success Rates

April 01, 2016
Market watch: Upcoming market catalysts in Q2 2016

March 09, 2016
Datamonitor Healthcare Showcases Benefits of $100m Informa (INF.L) Investment Program

February 18, 2016
Wall Street Horizon Partners with Informa’s BioMedTracker to provide FDA Drug Approval Dates and Pharmaceutical Intelligence to Investment Professionals

December 18, 2015
Market watch: Upcoming market catalysts in Q1 2016

October 13, 2015
Market watch: Upcoming market catalysts in Q4 2015

September 29, 2015
C&EN Supplement - The 2015 Top 20 Drugs in the Pipeline

August 20, 2015
Forbes - The FDA Is Basically Approving Everything. Here's The Data To Prove It

June 19, 2015
Market watch: Upcoming market catalysts in Q3 2015

June 15, 2015
BIO Industry Analysis: Emerging Therapeutic Company Investment and Deal Trends

March 13, 2015
Market watch: Upcoming catalysts in Q2 2015

January 22, 2015
Convert Catalysts into Profits: Sagient Research's Edward Stopke

December 12, 2014
Market watch: Upcoming catalysts in Q1 2015

November 03, 2014
TheStreet - Super Important Biotech and Drug Stock Events for November

October 07, 2014
Nature Reviews Drug Discovery - Market Watch: Upcoming catalysts in Q4 2014

July 01, 2014
Nature Reviews Drug Discovery - Market Watch: Upcoming catalysts in Q3 2014

March 24, 2014
Nature Reviews Drug Discovery - Market Watch: Upcoming market catalysts in Q2 2014

March 10, 2014
The Wall Street Journal - Pharmaceutical Scouts Seek New Star Drugs for Cancer, Diabetes

March 07, 2014
SCRIP Intelligence - Antimicrobial Resistance: Bioinfect 2013

February 10, 2014
Forbes - A Way To Increase Drug R&D Success Rates

January 21, 2014
Panel Discussion of 2014 Biotech Watchlist at 2014 Biotech Showcase

January 21, 2014
The Life Sciences Report 2014 Biotech Watchlist

January 13, 2014
New Study Shows the Rate of Drug Approvals Lower than Previously Reported

December 12, 2013
Seeking Alpha - Orphan Drug Designations: Why You Should Care

December 02, 2013
2014 FDA Drug Approval Decision Calendar

December 02, 2013
Eight Catalyst-Driven Biotechs Ready to Advance: Michael Hay and Jocelyn August

November 18, 2013
Seeking Alpha - Acadia's Pimavanserin Is The Next Blockbuster For Psychosis

November 18, 2013
The Wall Street Journal - Simulators Help Build a Better Drug Trial

October 07, 2013
Nature Medicine - First IL-6–blocking drug nears approval for rare blood disorder

October 03, 2013
Nature Reviews Drug Discovery - Market Watch: Upcoming market catalysts in Q4 2013

October 01, 2013
Forecasting Fortunes for US Approval

September 25, 2013
Sanofi cholesterol drug touted as potential $3-bln blockbuster. BioMedTracker sees sales of $3.7 billion by 2023

July 01, 2013
Nature Reviews Drug Discovery - Market watch: Upcoming market catalysts in Q3 2013

June 20, 2013
ISIS Pharmaceuticals: Finally On Target After All These Years

May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential

April 02, 2013
Nature Reviews Drug Discovery - Market watch: Upcoming market catalysts in Q2 2013

March 05, 2013
Celebrating National Rare Disease Day - A Bright Future for Orphan Disease Indications

February 25, 2013
New BioMedTracker.com Website Gives Subscribers Greater Access To Pharmaceutical Intelligence

February 11, 2013
Sagient Research Publishes Report on FDA and EMA Approval Rates

January 31, 2013
The Life Sciences Report Watchlist 2013

January 01, 2013
Nature Reviews Drug Discovery - Market Watch: Upcoming market catalysts in Q1 2013

January 01, 2013
Nature Reviews Drug Discovery - 2012 in reflection

December 21, 2012
The Street - Biotech Stock Mailbag: Amicus, Amarin, Oncothyreon - "BioMedTracker: Hands down, the best, most complete database"

November 30, 2012
Lessons from the Liver Meeting: Sagient's John Tucker Names Companies that Could Reignite the Hepatitis C Industry

November 09, 2012
PlacementTracker Presents Research on ATM (At the Market) Offerings During Growth Capital Investor Webinar

October 01, 2012
Nature Reviews Drug Discovery - Market Watch: Upcoming market catalysts in Q4 2012

August 21, 2012
The Street - 31 Drugs Facing FDA Approval in 2012-2013

August 13, 2012
Nature Biotechnology - Public biotech 2011—the numbers

August 06, 2012
The Street - Rethinking Idenix Pharma in Wake of Bristol's Hep C Blow Up

July 03, 2012
Nature Reviews Drug Discovery - Market Watch: Upcoming Market Catalysts in Q3 2012

April 09, 2012
Genetic Engineering & Biotechnology News - Studies Suggest that When It Comes to Drug Development Success, Size Matters

April 05, 2012
The Life Sciences Report Launch - Click to view site

March 30, 2012
Nature Reviews Drug Discovery - Market Watch: Upcoming Market Catalysts in Q2 2012

January 04, 2012
Nature Reviews Drug Discovery - 2011 in reflection (subscription required)

January 03, 2012
Nature Reviews Drug Discovery - Market Watch: Upcoming Market Catalysts in Q1 2012

November 15, 2011
SF Chronicle/Bloomberg News - Corporate venture funds boost biotech startups

October 26, 2011
SF Business Times - Biotech's new normal: Innovation but no VC money, risk

October 11, 2011
Nature Medicine: New Fee Structure Proposed by FDA Might Lead to More Talk

October 01, 2011
Nature Reviews Drug Discovery - Market Watch: Upcoming Market Catalysts in Q4 2011

September 08, 2011
BioMedTracker Announces Launch of AdComm Insight Service

July 01, 2011
Nature Reviews Drug Discovery - Market Watch: Upcoming Market Catalysts in Q3 2011

May 25, 2011
TheStreet - Biotech Calendar: 2011 FDA Drug Approvals

May 11, 2011
TheStreet - Cancer Stocks on Tap: ASCO Abstract Preview

April 01, 2011
Nature Reviews Drug Discovery - Upcoming Market Catalysts in Q2 2011

February 14, 2011
New Study Shows the Rate of Drug Approvals Lower than Previously Reported

January 31, 2011
Biotech Calendar: Key Dates for February

January 07, 2011
Nature Reviews Drug Discovery - Market Watch: Upcoming Market Catalysts in Q1 2011

January 07, 2011
Nature Reviews Drug Discovery - 2010 in Reflection

December 14, 2010
Nature News - Slim Spoils for Obesity Drugs

December 01, 2010
Nature Reviews Drug Discovery - Hepatitis Drugs Shine at Liver Meeting

November 29, 2010
Reuters - PREVIEW-Diet Drug Faces U.S. Test After Rivals Fall Short

November 09, 2010
Arena Pharmaceuticals' Fantasy Land

November 03, 2010
Nature Reviews Drug Discovery - First Oral Warfarin Alternative Approved in the US

October 14, 2010
Nature Biotechnology - Drug Pipeline: Q310

October 14, 2010
Genzyme MS Drug Data Remains Strong After 5 Years

October 11, 2010
Reuters - J&J Drug Offers Hope in Advanced Prostate Cancer

October 05, 2010
Reuters - Analysis: Multiple Sclerosis Drug a Wild Card in Genzyme Fight

October 04, 2010
Nature Reviews - Market Watch: Upcoming Market Catalysts in Q4 2010

September 09, 2010
BioMedTracker Announces Launch of Thought Leader Opinion Service

August 19, 2010
Nature News Briefing - Pharma's Next Blockbuster - HCV

August 13, 2010
Nature News - Boost for Drugs Against Hepatitis C

August 03, 2010
Nature Reviews - Impact of PDUFA on Regulatory Decision-Making

July 22, 2010
BioMedTracker Announces New Features

July 14, 2010
TheStreet.com - 10 Firms Expecting Clinical Trial Results

July 07, 2010
PlacementTracker Publishes First Half 2010 PIPE Market League Tables

July 05, 2010
Nature Reviews Drug Discovery - Upcoming Market Catalysts in Q3 2010

July 01, 2010
Nature Reviews Drug Discovery - Drug Pipeline: Q210

May 03, 2010
Nature Reviews Drug Discovery – Emerging companion diagnostics for cancer drugs

April 13, 2010
Reuters - Roche's Avastin on track for global top drug spot

April 06, 2010
Sagient Research Publishes Updated Report on FDA Approval Rates

April 05, 2010
Nature Reviews Drug Discovery - Key Clinical and Regulatory Events in Q2 2010

February 25, 2010
Reuters - A Bottle of Pills to Kick the Bottle

February 05, 2010
Nature Reviews Drug Discovery - 2009 FDA drug approvals

September 21, 2009
Thomson Reuters Launches Thomson Pharma Partnering Forecast with Licensed Data from BioMedTracker

September 05, 2009
Nature Reviews Drug Discovery - Novel pharmacotherapies for obesity poised to enter market

July 16, 2009
Sagient Research and Thomson Reuters Announce Strategic Partnership

July 01, 2009
Nature Reviews Drug Discovery - Novel obesity therapies set to attract spotlight in Q3 2009

April 30, 2009
Nature Reviews Drug Discovery – Diabetes Drugs Pass Cardiovascular Risk Check

April 01, 2009
Nature Reviews Drug Discovery – Pivotal Oncology Trials: Outlook for Q2 2009

January 30, 2009
Nature Reviews Drug Discovery – 2008 FDA Drug Approvals

January 20, 2009
PlacementTracker Publishes 2008 Australian Private Placement League Tables

January 05, 2009
Nature Reviews Drug Discovery – FDA PDUFA Goals Missed

December 18, 2008
TheStreet.com - Biotech Clinical Trials to Watch in 2009

September 16, 2008
Forbes - Data On Bone Drug Brightens Amgen's Future

July 07, 2008
TheStreet.com - Biotech Stocks: Second Half 2008 Preview

July 01, 2008
Nature Reviews Drug Discovery - ASCO presentations highlight value of cancer biomarkers

June 30, 2008
The Wall Street Journal - Drug Makers Say FDA Safety Focus Is Slowing New-Medicine Pipeline

February 04, 2008
USA Today - FDA caution, 'research drought' cuts drug approvals

February 01, 2008
Nature Reviews Drug Discovery - 2007 FDA drug approvals: a year of flux

January 09, 2008
Sagient Research Reports Significant Decline in FDA Drug Approval Rate

January 09, 2008
CNBC - FDA In 2007: Not Much Love For New Drugs

December 12, 2007
TheStreet.com - Biotech Trial Dates to Watch in '08

December 05, 2007
TheStreet.com - Biotech Stocks Face Make-or-Break FDA Rulings

October 31, 2007
CNBC - One Pill, No Problems

October 23, 2007
TheStreet.com - After Exubera, Uncertainty Reigns

October 01, 2007
Sagient Research Launches CatalystTracker

July 20, 2007
TheStreet.com - These 10 Biotechs Have Drugs Near Finish Line

May 22, 2007
TheStreet.com - Glaxo Aims to Recover

February 17, 2007
TheStreet.com - Feuerstein's Biotech Mailbag

December 05, 2006
TheStreet.com - Pfizer Misstep Induces Angst

September 27, 2006
TheStreet.com - Biotechs' Compound Conundrum

March 22, 2006
TheStreet.com - Cephalon Overcomes Sparlon Scare

February 21, 2006
TheStreet.com - Sanofi Stumbles After Drug Setback

October 21, 2005
Sagient Research Announces Approval of Reverse Stock Split and Going Private Transaction.

August 05, 2005
TheStreet.com - Crunch Time at Teva

July 20, 2005
TheStreet.com - Lilly Makes Bid for Respect

October 10, 2002
PCS Research Technology Unveils BiotechTracker Research Service